BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12373485)

  • 21. Protection of phagocytosed bacteria against antimicrobial agents.
    Solberg CO; Hellum KB
    Scand J Infect Dis Suppl; 1978; (14):246-50. PubMed ID: 360374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.
    Kristiansen MM; Leandro C; Ordway D; Martins M; Viveiros M; Pacheco T; Molnar J; Kristiansen JE; Amaral L
    In Vivo; 2006; 20(3):361-6. PubMed ID: 16724671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure of chlorpromazine to 266 nm laser beam generates new species with antibacterial properties: contributions to development of a new process for drug discovery.
    Pascu ML; Danko B; Martins A; Jedlinszki N; Alexandru T; Nastasa V; Boni M; Militaru A; Andrei IR; Staicu A; Hunyadi A; Fanning S; Amaral L
    PLoS One; 2013; 8(2):e55767. PubMed ID: 23405212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Garenoxacin-induced increase of CD11b expression on human polymorphonuclear neutrophils does not affect phagocytosis and killing of Staphylococcus aureus.
    Grüger T; Reiners AL; Schnitzler N; Brandenburg K; Zündorf J
    J Infect Chemother; 2011 Apr; 17(2):291-6. PubMed ID: 20706761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ceftriaxone on the phagocytosis and intracellular killing of Staphylococcus aureus by human macrophages.
    Tullio V; Cuffini AM; Cavallo R; Allocco A; Carlone NA
    J Chemother; 1994 Jun; 6(3):177-83. PubMed ID: 7983500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents.
    Pérez Fernández P; Herrera I; Martínez P; Gómez-Lus ML; Prieto J
    Chemotherapy; 1995; 41(1):45-9. PubMed ID: 7875021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages.
    Kubica M; Guzik K; Koziel J; Zarebski M; Richter W; Gajkowska B; Golda A; Maciag-Gudowska A; Brix K; Shaw L; Foster T; Potempa J
    PLoS One; 2008 Jan; 3(1):e1409. PubMed ID: 18183290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carpobrotus edulis methanol extract inhibits the MDR efflux pumps, enhances killing of phagocytosed S. aureus and promotes immune modulation.
    Ordway D; Hohmann J; Viveiros M; Viveiros A; Molnar J; Leandro C; Arroz MJ; Gracio MA; Amaral L
    Phytother Res; 2003 May; 17(5):512-9. PubMed ID: 12748989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enumeration of phagocytosed Staphylococcus aureus inside cells of the mouse macrophage cell line J774 by bioluminescence, fluorescence and viable counting techniques.
    Sunderland J; Brenwald N; Smith E; Andrews JM; Wise R; Honeybourne D
    J Biolumin Chemilumin; 1995; 10(5):291-9. PubMed ID: 8533611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.
    Fietta A; Boeri P; Colombo ML; Merlini C; Gialdroni Grassi G
    Chemotherapy; 1993; 39(1):48-54. PubMed ID: 8444060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro efficacy of several antibiotics against intracellular S. aureus in chronic granulomatous disease.
    Zimmerli W; Lew PD; Suter S; Wyss M; Waldvogel FA
    Helv Paediatr Acta; 1983 Mar; 38(1):51-61. PubMed ID: 6862995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
    Shi G; Chen X; Wang H; Wang S; Guo X; Zhang X
    J Antibiot (Tokyo); 2012 May; 65(5):229-36. PubMed ID: 22334239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
    Kaczmarska L; Jakoniuk P
    Med Dosw Mikrobiol; 2003; 55(1):1-10. PubMed ID: 12908409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing.
    Oddera S; Silvestri M; Sacco O; Eftimiadi C; Rossi GA
    J Lab Clin Med; 1994 Aug; 124(2):293-301. PubMed ID: 8051494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bovine pulmonary alveolar macrophages: antemortem recovery and in vitro evaluation of bacterial phagocytosis and killing.
    Trigo E; Liggitt HD; Breeze RG; Leid RW; Silflow RM
    Am J Vet Res; 1984 Sep; 45(9):1842-7. PubMed ID: 6497143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phagocytosis and killing of A-protein positive Staphylococcus aureus in the presence of low doses of antibiotics.
    Mascellino MT; De Vito ML; Maclean Feeney E; Iegri F; Catania S
    Drugs Exp Clin Res; 1989; 15(2):63-9. PubMed ID: 2737081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bacampicillin and ampicillin on the phagocytic, microbicidal functions of human macrophages.
    Cuffini AM; Carlone NA; Tullio V
    J Chemother; 1991 Jan; 3 Suppl 1():122-7. PubMed ID: 12041745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity against intraosteoblastic Staphylococcus aureus.
    Valour F; Trouillet-Assant S; Riffard N; Tasse J; Flammier S; Rasigade JP; Chidiac C; Vandenesch F; Ferry T; Laurent F
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2029-36. PubMed ID: 25605365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.